Clinical Trial Update: The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the efficacy of lopinavir/ritonavir and arbidol in coronavirus infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infections

Drugs mentioned

• ARbidol (umifenovir)
• Lopinavir and Ritonavir (lopinavir/ritonavir)

Snippet

Sponsor: Guangzhou 8th People's Hospital | Conditions: Coronavirus Infections | Phase 4 | Status: COMPLETED